Evolution of vaccinia virus-specific CD8+ cytotoxic T-lymphocyte responses in primary vaccinees and revaccinees

Clin Diagn Lab Immunol. 2004 Jul;11(4):758-61. doi: 10.1128/CDLI.11.4.758-761.2004.

Abstract

Determination of successful vaccination with vaccinia virus is based on visual confirmation of a dermal response (take). Some revaccinees do not manifest a take, which may be due to a preexisting immunity rather than to poor technique or inadequate virus. Cytotoxic T-lymphocyte (CTL) response appears to be the most important immune defense in limiting response to vaccination. We evaluated vaccinia virus-specific CTL responses in revaccinees. Subjects with and without takes displayed comparable CTL responses. Vaccinia virus-specific CD8+ CTL responses may be useful in interpreting the response to vaccination, particularly in individuals who are revaccinated and have difficult-to-interpret visual takes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Female
  • Humans
  • Interferon-gamma / blood
  • Interferon-gamma / immunology
  • Male
  • Middle Aged
  • Skin Tests*
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocyte Subsets / virology
  • T-Lymphocytes, Cytotoxic / immunology*
  • T-Lymphocytes, Cytotoxic / virology
  • Vaccination*
  • Vaccinia virus / immunology*

Substances

  • Interferon-gamma